Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Schwartz SophiaChief Legal Officer, Secretary | Option exercise · 10b5-1 plan | M | — 29.5K sh | Oct 19, 2026 |
| 0 | Schwartz SophiaChief Legal Officer, Secretary | Tax withholding · 10b5-1 plan | F | $32K 12.3K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 0 | Schwartz SophiaChief Legal Officer, Secretary | Option exercise · 10b5-1 plan | M | — 24.2K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 0 | Tariq MusaDirector | Option exercise · 10b5-1 plan | M | — 250 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 0 | Buckley MerileeCHIEF ACCOUNTING OFFICER | Option exercise · 10b5-1 plan | M | $355K 5,076 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 0 | Tariq MusaDirector | Open-market sale · 10b5-1 plan | SELL | $19K 116 sh | Oct 19, 2026 traded Oct 16, 2026 |
| 0 | Radakovich Lynn VojvodichDirector | Option exercise · 10b5-1 plan | M | — 20.3K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 63 | EEME Energy SPV I, LLC10% Owner | Open-market purchase | BUY | $142.08M 119.40M sh | Oct 16, 2026 traded Oct 16, 2026 |
| 43 | Lillie James WoodruffChief Scientific Officer | Open-market sale | SELL | $93K 11.5K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 39 | Kreitzer AnatolChief Discovery Officer | Open-market sale | SELL | $96K 12.2K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 39 | Ryan Christina MDirector | Open-market purchase | BUY | $100 2 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 38 | Mindlin Marcos MarceloDirector, 10% Owner | Open-market purchase | BUY | $35.14M 435.0K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 36 | Hanson KristopherGeneral Counsel | Open-market sale | SELL | $73K 9,020 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 35 | Bawel Zachary WDirector | Open-market purchase | BUY | $17K 344 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 32 | Seger Andrew MDirector | Open-market purchase | BUY | $100 2 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 32 | Foff Erin PennockChief Medical Officer | Open-market sale | SELL | $124K 15.4K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 28 | Marinaro MichaelEVP, Pres MedSurg and Americas | Open-market sale · 10b5-1 plan | SELL | $1.00M 10.4K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 27 | Stirrup AllisonChief Human Resources Officer | Open-market sale · 10b5-1 plan | SELL | $207K 922 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 26 | Atay OguzhanDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $303K 3,083 sh | Oct 16, 2026 traded Oct 14, 2026 |
| 25 | Jergensen JoshuaPresident & COO | Open-market sale · 10b5-1 plan | SELL | $1.78M 40.0K sh | Oct 16, 2026 traded Oct 14, 2026 |
| 23 | Atay OguzhanDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $100K 980 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 23 | Atay OguzhanDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $128K 1,276 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 22 | Pittas Aristeidis PDirector | Open-market purchase | BUY | $14K 300 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 22 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $3.68M 77.5K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 22 | Murphy Kevin MichaelDirector, See Remarks | Open-market sale · 10b5-1 plan | SELL | $399K 1,776 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 22 | Costanzo Brian J.Chief Financial Officer | Other acquisition or disposition | J | $3,000 2 sh | Oct 16, 2026 traded Sep 30, 2026 |
| 22 | Boylston LukeChief Accounting Officer | Tax withholding | F | $134K 19.7K sh | Oct 16, 2026 traded Oct 13, 2026 |
| 22 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.16M 24.8K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 22 | Arison GeorgeDirector, CHIEF EXECUTIVE OFFICER | Tax withholding | F | $2.87M 190.8K sh | Oct 16, 2026 traded Oct 14, 2026 |
| 22 | Pittas Aristeidis PDirector | Open-market purchase | BUY | $14K 300 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 21 | Olson Peter AChief Scientific Officer | Grant or award | A | — 19.5K sh | Oct 16, 2026 traded Oct 14, 2026 |
| 21 | Josephson NeilChief Medical Officer | Grant or award | A | — 31.0K sh | Oct 16, 2026 traded Oct 14, 2026 |
| 21 | Lowenkron Melissa BChief Brand Officer | Grant or award | A | — 65.2K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 21 | Paradise AndrewDirector, Chief Executive Officer, 10% Owner | Option exercise | M | — 142.9K sh | Oct 16, 2026 traded Oct 14, 2026 |
| 21 | Webster AaronEVP, Global Chief Risk Officer | Option exercise | M | — 2,622 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 21 | Webster AaronEVP, Global Chief Risk Officer | Option exercise | M | — 5,900 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 21 | Tubman Casey JGROUP PRESIDENT | Grant or award | A | — 16.7K sh | Oct 16, 2026 traded Oct 14, 2026 |
| 20 | Atay OguzhanDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $9,900 100 sh | Oct 16, 2026 traded Oct 14, 2026 |
| 20 | Natali ChrisSVP, Chief Accounting Officer | Tax withholding | F | $72K 1,291 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 20 | Atay OguzhanDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $14K 133 sh | Oct 16, 2026 traded Oct 15, 2026 |